Medical Innovation Exchange

Novartis looking for new homes for midphase asthma, eye disease and NASH assets after pipeline review


Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.